Literature DB >> 2802032

Elective versus therapeutic neck dissection in early carcinoma of the oral tongue.

A R Fakih1, R S Rao, A M Borges, A R Patel.   

Abstract

A prospective, randomized trial was carried out to assess the value of elective versus therapeutic neck dissection in early squamous cell carcinoma of the oral tongue. Disease-free survival (median follow-up 20 months) was 52 percent versus 63 percent in patients who underwent hemiglossectomy alone and those who underwent hemiglossectomy and radical neck dissection, respectively (difference not statistically significant). Patients with a tumor depth of less than 4 mm did significantly better than those with a tumor depth of greater than 4 mm; they were also more likely to have uninvolved nodes at elective radical neck dissection compared with those with a tumor depth of greater than 4 mm. However, when the survival rates of patients in the two treatment groups were compared with respect to a tumor depth of 4 mm, there was no significant difference between the hemiglossectomy and the hemiglossectomy and radical neck dissection groups. A policy of interval elective radical neck dissection only in those with a tumor depth of greater than 4 mm may optimize cure rates and avoid neck dissection in those unlikely to develop neck recurrence.

Entities:  

Mesh:

Year:  1989        PMID: 2802032     DOI: 10.1016/0002-9610(89)90122-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  69 in total

Review 1.  Management of the clinically negative (N0) neck.

Authors:  Karen T Pitman; Robert Dean
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

Review 2.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

Review 3.  Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

Authors:  R A Ord
Journal:  Oral Maxillofac Surg       Date:  2012-05-13

Review 4.  Cancer of the gingiva.

Authors:  Rusana Bark; Claes Mercke; Eva Munck-Wikland; Natalie Ann Wisniewski; Lalle Hammarstedt-Nordenvall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-04       Impact factor: 2.503

5.  Neck observation versus elective neck dissection in management of clinical T1/2N0 oral squamous cell carcinoma: a retrospective study of 232 patients.

Authors:  Xiangqi Liu; Xiaomei Lao; Lizhong Liang; Sien Zhang; Kan Li; Guiqing Liao; Yujie Liang
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

6.  Prognostic implication of NOTCH1 in early stage oral squamous cell cancer with occult metastases.

Authors:  Shan Wang; Haixia Fan; Jiankai Xu; Eryang Zhao
Journal:  Clin Oral Investig       Date:  2017-09-02       Impact factor: 3.573

7.  Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma.

Authors:  Yufeng Li; Shuting Bai; William Carroll; Dan Dayan; Joseph C Dort; Keith Heller; George Jour; Harold Lau; Carla Penner; Michael Prystowsky; Eben Rosenthal; Nicolas F Schlecht; Richard V Smith; Mark Urken; Marilena Vered; Beverly Wang; Bruce Wenig; Abdissa Negassa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-12-19

Review 8.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

9.  Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study.

Authors:  Mehmet Bugrahan Duz; Omer Faruk Karatas; Esra Guzel; Nesrettin Fatih Turgut; Mehmet Yilmaz; Chad J Creighton; Mustafa Ozen
Journal:  Cell Oncol (Dordr)       Date:  2015-12-09       Impact factor: 6.730

10.  Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy.

Authors:  Su Jung Shim; Jihye Cha; Woong Sub Koom; Gwi Eon Kim; Chang Geol Lee; Eun Chang Choi; Ki Chang Keum
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.